The Institute on Global Drug Policy


	CURRENT ISSUE	PREVIOUS ISSUES	COMMENTARY	RESPONSES	SEARCH	ABOUT US

PREVIOUS ISSUES

VOLUME 3, ISSUE 4 - Winter 2010
go to this issue

An Overview of Present and Future Drug Testing
David M. Martin, Ph.D.
Drug Testing in Clinical Settings
Robert L. DuPont, M.D.
President, Institute for Behavior and Health
Drug Testing of Students
David Evans, J.D.
Drug Testing In The Workplace: An historical and economic examination
Calvina Fay

VOLUME 3, ISSUE 3 - FALL 2009
go to this issue

Alcohol Promotion on Facebook
Sarah Mart, Jacob Mergendoller, Michele Simon
Marin Institute, San Rafael, California, United States
Adolescent Brain Development and Alcohol Abuse
Ken C. Winters, Ph.D.
Professor, Department of Psychiatry, University of Minnesota
Senior Scientist, Treatment Research Institute
Reducing Youth Access – The Impact of Policy Change
Michelle Voth, Executive Director, Kansas Family Partnership

VOLUME 3, ISSUE 2 - SUMMER 2009
go to this issue

Marijuana Dispensaries and the Federal Government: Recommendations to the Obama Administration 2009: Part 1
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., DCBA Law & Policy
Marijuana Dispensaries and the Federal Government: Recommendations to the Obama Administration 2009: Part 2
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., DCBA Law & Policy
A Review of the Research on the Risks and Harms Associated to the Use of Marijuana

Jordan Diplock, Irwin Cohen, and Darryl Plecas School of Criminology and Criminal Justice, University College of the Fraser Valley, Abbotsford, British Columbia, Canada

VOLUME 3, ISSUE 1 - SPRING 2009
go to this issue

A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 1
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., Vera R. Leopold, B.A., Jana L. Wichelecki, B.A.
A Vital Balancing Act: Multi-Sector Approaches to Preventing Prescription Drug Abuse in the United States while Ensuring Adequate Patient Access to Medications: Part 2
Andrea G. Barthwell, M.D., Michael C. Barnes, Esq., Vera R. Leopold, B.A., Jana L. Wichelecki, B.A.
Barack Obama on Medical Marijuana
Robert L. DuPont, M.D.

VOLUME 2, ISSUE 4 - WINTER 2008
go to this issue

What I Wish From Our New Administration
David A. Gross, MD, DFAPA
Cutting The Gordian Knot of Drug Addiction Confusion
Dr Stuart Reece, General Practitioner in Brisbane, Australia
Is the Glass Half Empty, Half Full or Dry?
Tavis Glassman, PhD, MPH, CHES
Afghanistan: An Enduring Problem
Ian Oliver

VOLUME 2, ISSUE 3 - FALL 2008
Coordinating Patient Care and Predicting Alcohol Consumption: Expectations and Behavior
go to this issue

Addiction in Clinical Practice: Psychiatry
William M. Greene, MD; Mark E. Sylvester, MD; Lisa J. Merlo, PhD
Substance Abusing Patients in the Primary Care Setting: They Deserve Treatment Too
Kendall M. Campbell, MD
Emergency Medicine and Addiction Medicine: Much in Common
Daniel P. Logan, M.D., F.A.C.E.P.
Using the Theory of Planned Behavior to Predict Alcohol Consumption among College Students on Game Day
Tavis Glassman PhD, MPH, CHES, Virginia Dodd, PhD, MPH, Jiunn-Jye Sheu, PhD, MSPH, CHES, Barbara A. Rienzo, PhD, Alexander C. Wagenaar, PhD

VOLUME 2, ISSUE 2 - SUMMER 2008
Current Issues in Drug Abuse and Treatment: Implications for Identifying Risk
go to this issue

Patterns and Characteristics of Prescription Opioid Abuse in the United States
Theodore J. Cicero, PhD¹, Michael Lynskey, PhD¹, Alexandre Todorov, PhD¹, James Inciardi, PhD², Hilary Surratt, PhD²
Neurobiology of Addiction and the Adolescent Brain
Deborah R. Simkin, M.D., Section Head, Division of Child and Adolescent Psychiatry, Residency Director Department of Psychiatry, University of South Alabama College of Medicine
Physicians Impaired by Substance Abuse Disorders
Kimberly B. Gold, MS4, Yale University School of Medicine, Scott A. Teitelbaum, M.D., F.A.A.P., A.S.A.M., Associate Professor, University of Florida School of Medicinen
The Use of Intervention and Case Management Models in Maximizing Recovery and Reducing Relapse Risks for Substance Abusers
Kate Caravella, CAC, NCAC 1, BRI 1

VOLUME 2, ISSUE 1 - SPRING 2008
Prescribing Controlled Substances: A Physician's Dilemma, a Patient's Responsibility and the Public's Protection
go to this issue

Prescribing Controlled Substances Reconsidered
Eric A. Voth, M.D., FACP, Chairman, The Institute on Global Drug Policy
Thawing the Chill: The U.S. Drug Enforcement Administration, Physicians and the Controlled Substances Act
Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, DEA
Addiction Treatment: A Psychiatrist’s Perspective
David A. Gross, MD, Distinguished Fellow of the American Psychiatric Association
Interventional Pain Procedures: Understanding their Role in Clinical Practice
Ian J. Kucera, M.D., Pharm.D., Director of Pain Medicine Stormont-Vail Healthcare, Topeka, KS

VOLUME 1, ISSUE 4 - WINTER 2007
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue

Harm Reduction – the Idea and the Ideology
Professor Dr A. Hamid Ghodse, Member and Past President, INCB.
When Harm minimization is not harm minimization – Australia as a Case Study
Stuart Reece MBBS (Hons), FRCS (Ed.), FRCS (Glas.), MD, FRACGP
The “Local” Matters: A Brief History of the Tension Between Federal Drug Laws and State and Local Policy
Kevin A. Sabet, Ph.D.
Putting ethics in its place – right at the heart of drug policy debates
Dr Gregory K Pike, PhD
History of Harm Reduction - Provenance and Politics, Part 3
Peter Stoker C. Eng. – Director, National Drug Prevention Alliance, UK

VOLUME 1, ISSUE 3 - FALL 2007
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue

The Effectiveness of Needle Exchange Programmes for HIV Prevention - A Critical Review
Kerstin Käll, Ulric Hermansson, Ellen J. Amundsen, Klas Rönnbäck and Sten Rönnberg
A Critical Evaluation of the Effects of Safe Injection Facilities
Garth Davies
The Public Health Dangers of Drug Abuse in Prisons
Ian Oliver
History of Harm Reduction - Provenance and Politics, Part 2
Peter Stoker C. Eng.

VOLUME 1, ISSUE 2 - SUMMER 2007
Harm Reduction: Background, Outcomes, Appraisals and Implications for Future Drug Policy
go to this issue

The Lure and the Loss of Harm Reduction in UK Drug Policy and Practice
Neil McKeganey, BA, MSc, PhD, FRSA
A Critique of Canada’s INSITE Injection Site and its Parent Philosophy: Implications and Recommendations for Policy Planning
Colin Mangham, PhD
Is It Harm Reduction - Or Harm Continuation?
Peter O’Loughlin
History of Harm Reduction – Provenance and Politics, Part 1
Peter Stoker C. Eng.

VOLUME 1, ISSUE 1 - SPRING 2007
Marijuana: The present challenge and the future of cannabinoid research
go to this issue

Marijuana and cannabinoid research: Current status and future potential
Eric A. Voth, MD, FACP
From Mockery to Medicine: The Story of the Development of a Serious Modern Medicine
Andrea G. Barthwell, MD, FASAM
Marijuana and Adolescents
Edward A. Jacobs, MD, FAAP

Information for Authors